Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

17.53
-0.1200-0.68%
Pre-market: 17.29-0.2400-1.37%07:39 EDT
Volume:1.29M
Turnover:22.59M
Market Cap:36.04B
PE:9.21
High:17.79
Open:17.59
Low:17.37
Close:17.65
52wk High:18.19
52wk Low:8.57
Shares:2.06B
Float Shares:237.00M
Volume Ratio:0.87
T/O Rate:0.54%
Dividend:0.99
Dividend Rate:5.65%
EPS(TTM):1.90
EPS(LYR):1.16
ROE:15.95%
ROA:7.31%
PB:1.76
PE(LYR):15.05

Loading ...

Ecopetrol reports cybersecurity incident

TIPRANKS
·
Jul 19

Ecopetrol's Acquisition Appeal Backed by Brazilian Regulator, Reviving Takeover Process

Deep News
·
Jul 17

Press Release: Ecopetrol Reports CVM Decision on Appeal Related to the Tender Offer

Dow Jones
·
Jul 16

Ecopetrol SA (EC) Gets a Sell from Morgan Stanley

TIPRANKS
·
Jul 16

Over 600 Drugs Pass Preliminary Review for China's 2026 National Reimbursement Drug List

Stock News
·
Jul 14

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity

GlobeNewswire
·
Jul 09

Zoetis granted EC Marketing Authorization for Poulvac Procerta vaccine

TIPRANKS
·
Jul 07

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

GlobeNewswire
·
Jul 07

AbbVie says Tepkinly combo approved by EC for lymphoma treatment

TIPRANKS
·
Jul 07

Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

GlobeNewswire
·
Jul 02

Ecopetrol gets account receivable payment from Fuel Price Stabilization Fund

TIPRANKS
·
Jul 01

Ecopetrol Receives $292.7 Million Colombian Government Payment for Q2 2025

MT Newswires Live
·
Jul 01

EC Healthcare Forecasts Wider Full-Year Loss

MT Newswires Live
·
Jun 25

EC Healthcare Flags Wider FY2026 Loss on Heavy Non-Cash Impairments

TIPRANKS
·
Jun 25

Gilead announces EC grants marketing authorization for Trodelvy

TIPRANKS
·
Jun 23

BUZZ-Colombian ADRs rise after right-wing presidential candidate's win

Reuters
·
Jun 22

3 High Dividend Stocks With Margins And Balance Sheet Risk

Simply Wall St.
·
Jun 20

Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026

GlobeNewswire
·
Jun 16

Ecopetrol Strikes Collective Bargaining Agreement With Oil Workers Union

MT Newswires Live
·
Jun 15

Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome

GlobeNewswire
·
Jun 13